ABRAXANE® (nanoparticle albumin-bound paclitaxel) is used for the treatment of patients with:
NERLYNX® (neratinib) is currently under regulatory evaluation in Australia.
ICLUSIG® (ponatinib HCl) is used to treat adults with chronic myeloid leukaemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) who are no longer benefiting from treatment with other medicines.
APLIDIN® (plitidepsin) is currently under regulatory evaluation in Australia.
GLIOLAN® (aminolevulinic acid hydrochloride) is an orally administered drug used for the visualisation of certain brain tumours (called glioblastoma multiforme) during tumour surgery.
To view a brief video of fluorescence-guided glioma surgery using GLIOLAN, click here
Fluorescence-guided surgery with GLIOLAN is available at the following hospitals:
Australian Hospitals | New Zealand Hospitals